§ 13F · FUND PROFILE
RA CAPITAL MANAGEMENT, L.P..
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · — (13F)Positions · 86Turnover · — · Q1Filed · May 15, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$869M deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q1 2026
FILED MAY 15, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q1 |
|---|---|---|---|---|---|---|
| 1 | ASND | ASCENDIS PHARMA A/S - ADR | 10.28M | $2.4B | 24.9% | ±0% |
| 2 | PCVX | VAXCYTE INC | 11.47M | $667M | 7.1% | +7% |
| 3 | RYTM | RHYTHM PHARMACEUTICALS INC | 6.67M | $580M | 6.1% | ±0% |
| 4 | TYRA | TYRA BIOSCIENCES INC | 12.20M | $467M | 5.0% | ±0% |
| 5 | SION | SIONNA THERAPEUTICS INC | 9.91M | $397M | 4.2% | ±0% |
| 6 | EWTX | EDGEWISE THERAPEUTICS INC | 10.43M | $328M | 3.5% | ±0% |
| 7 | NAMS | NEWAMSTERDAM PHARMA CO NV | 9.55M | $306M | 3.2% | ±0% |
| 8 | NUVL | NUVALENT INC-A | 2.53M | $260M | 2.8% | +35% |
| 9 | DNTH | DIANTHUS THERAPEUTICS INC | 2.61M | $219M | 2.3% | +62% |
| 10 | MLYS | MINERALYS THERAPEUTICS INC | 7.69M | $208M | 2.2% | +5% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE RA SIGNAL
AC read
RA CAPITAL MANAGEMENT, L.P. is classified as a Other fund.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q1 2026
Steady book
+0 buys · −0 exits · 0 changed
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed